What you should know:
– Samsung’s Galaxy Watch has received De Novo clearance from the US Food and Drug Administration (FDA) for its sleep apnea detection feature.
– This marks a significant advancement in wearable technology, making it the first of its kind to be approved by the FDA to detect potential sleep apnea.
Defining sleep apnea
Sleep apnea is a common, chronic sleep disorder in which breathing repeatedly stops and starts during sleep. This can lead to disruptions in oxygen supply, reduced sleep quality and daytime fatigue. Untreated, sleep apnea can increase the risk of cardiovascular diseases like heart failure and stroke.
How does the sleep apnea feature work?
The Samsung Galaxy Watch’s sleep apnea feature uses built-in sensors to monitor your sleep patterns, including blood oxygen levels. By analyzing this data over a two-night period, the watch can detect signs of moderate to severe obstructive sleep apnea (OSA). It’s important to note that this feature does not diagnose sleep apnea and is intended for people over the age of 22 who have not yet been diagnosed. If the feature detects potential signs of OSA, it encourages users to seek professional medical attention. This new Galaxy Watch feature could help identify potential cases earlier, allowing individuals to seek treatment and potentially improve their overall health.
The sleep apnea feature will be available on the Galaxy Watch series in the US via the Samsung Health Monitor app in Q3 2024.